Bio-Rad Laboratories Class BBIO.B
13F holders, Q3 2025 (September 30)5holders
1new positions
1sold out
$279.71avg. 13F price*
At the end of Q3 2025, 5 institutions reported holding Bio-Rad Laboratories Class B (BIO.B) in their 13F filings, unchanged from Q2 2025. 1 opened new positions and 1 sold out. The largest holders were CSS LLC ($309K), Focus Partners Wealth ($209K) and Morgan Stanley ($195K).
- Company
- Bio-Rad Laboratories Class B
- CUSIP
- 090572108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $209K |
| Exits | 1 | $716 |
All 13F filers, Q2 2025 → Q3 2025: 760 shares bought and 3 shares sold, net +757 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| CSS LLC | 0.05% | No change | 1,092 | $309K |
| Focus Partners Wealth | 0.00% | New | 760 | $209K |
| Morgan Stanley | 0.00% | No change | 712 | $195K |
| Wells Fargo & Company | 0.00% | No change | 170 | $48K |
| Whittier Trust Co. | 0.00% | No change | 160 | $48K |
"% of holder's portfolio" is BIO.B's weight in each manager's 13F, not the share of Bio-Rad Laboratories Class B the manager owns.